Skip to main content
On Demand

GLPRAs: Turning the “Tide” for Obesity


Total Credits: 1

Average Rating:
Not yet rated
State Associations:
VOMA - Virginia
Faculty:
Joynita Nicholson
Duration:
57 Minutes
Expiration:
Never expires.


Description

Obesity is a major public health problem and affects almost half the adults in the United States. It is a complex, chronic disease with many causes and several FDA-approved medications are currently available to be prescribed in conjunction with nutritional counseling, physical activity and behavioral therapy or surgical interventions. GLP1 RAs have become a Hollywood hot topic and a research hot spot for weight management and associated diseases. This topic is important because Obesity is now the most common chronic medical problem seen by primary care physicians. It puts individuals at increased health risk for other chronic diseases and increases all-cause mortality. Yet, it is often under recognized, under diagnosed and under treated. Since the 1930s, physicians stigmatized people with Obesity and believed that their excess weight is caused by lack of willpower to push back from the table, laziness preventing physical activity, or stating it is purely a lifestyle choice. The tides are turning in healthcare and it is now well studied and scientifically supported that Obesity is caused by more than behavior but is due to biology. It is more than a mindset. It is a true medical condition and it is not simply a condition caused by a lifestyle choice but rather is a lifelong disease requiring comprehensive, multidisciplinary treatment for a lifetime. This topic will cover this new paradigm shift and herald on the positive impact GLP1 RAs have had on the weight reduction and overall health of patients with Obesity.  Attendees will learn strategies to safely prescribe GLP1 RAs and achieve optimal results.

Learning Objectives:

  • Briefly review obesity including its prevalence, associated medical conditions, goals of treatment and approaches for therapeutic care
  • List the current FDA approved anti-obesity medications for adults and pediatric populations
  • Identify benefits and barriers associated with GLP1RA use
  • Discuss how to select the appropriate patient for prescribing GLP1RAs, how to safely prescribe them to achieve optimal outcomes

Handouts

Faculty

Joynita Nicholson Related Seminars and Products


Dr. Joynita Nicholson is an award-winning, passionate integrative concierge physician at WellcomeMD. She received her medical degree and her Academic Leadership Fellowship from Ohio University Heritage College of Osteopathic Medicine. She is board certified in Obesity Medicine (DABOM) and Family Practice and Osteopathic Medicine (AOBFP). For over 20 years she has compassionately partnered with her patients providing them preventative, high quality, comprehensive care while enthusiastically empowering them with evidence-based knowledge to improve their weight, overall health and wellbeing yielding life-changing results. During her free time, Dr. Nicholson enjoys traveling across the country by airplane, radio waves, or virtually as an invited, accomplished, well-received motivational and informational public speaker who with great joy educates her audiences on health topics in impactful ways.

Disclosures: None


Accreditation Information

The Virginia Osteopathic Medical Association (VOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. VOMA designates this program for a maximum of 1 AOA Category 1A CME credits and will report CME credits commensurate with the extent of the physician’s participation.

​Grievances regarding program administration and reporting of AOA CME credits will be handled on an individual basis Initially, all grievances should be directed to VOMA Executive Director. Participants with grievances that cannot be resolved will be sent to the AOA Council on CME , 142 East Ontario Street, Chicago, IL 60611.

Reviews